1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Pulmonary Embolism in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonopoulou, S; Demopoulos, C; Theoharides, TC | 1 |
| Hechtman, HB; Shepro, D; Valeri, CR | 1 |
| Goguel, A; Houbouyan, L; Rosenthal, D; Roussi, J; Toulemonde, F | 1 |
| Gilani, AH; Saeed, SA | 1 |
| Kawakami, Y; Kawatake, H | 1 |
| Kanazawa, T; Onodera, K; Takanashi, S; Yasugahira, H | 1 |
| Kitsiouli, EI; Lekka, ME; Nakos, G | 1 |
| Fiz, JA; Monreal, M; Monsó, E; Morera, J; Roncalés, J; Ruiz, J; Sala, H | 1 |
| Andrew, M; Coles, J; Rabinovitch, M; Trusler, GA; Turner-Gomes, SO; Williams, WG | 1 |
| Klee, A; Schmid-Schönbein, GW; Seiffge, D | 1 |
3 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Pulmonary Embolism
| Article | Year |
|---|---|
COVID-19, microthromboses, inflammation, and platelet activating factor.
Topics: Antiviral Agents; Blood Platelets; COVID-19; Cyproheptadine; Disseminated Intravascular Coagulation; Gene Expression Regulation; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Lung; Luteolin; Mast Cells; Platelet Activating Factor; Pulmonary Embolism; Quercetin; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Role of humoral mediators in adult respiratory distress syndrome.
Topics: Animals; Arachidonic Acids; Chemotaxis, Leukocyte; Chromones; Dogs; Guinea Pigs; Humans; Hypertension, Pulmonary; Inflammation; Ketanserin; Leukocyte Count; Leukocytes; Lung; Piperidines; Platelet Activating Factor; Pulmonary Embolism; Respiratory Distress Syndrome; Serotonin; Serotonin Antagonists; SRS-A; Thromboxane A2 | 1984 |
[Pulmonary thromboembolism and IgE].
Topics: Aged; Female; Humans; Immunoglobulin E; Platelet Activating Factor; Pulmonary Embolism; Transforming Growth Factor beta | 1993 |
7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Pulmonary Embolism
| Article | Year |
|---|---|
[Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia].
Topics: Adult; Blood Coagulation Factors; Female; Heparin; Humans; Molecular Weight; Platelet Activating Factor; Platelet Aggregation; Pulmonary Embolism; Thrombocytopenia | 1983 |
Antithrombotic activity of clove oil.
Topics: Animals; Arachidonic Acids; Blood Platelets; Eugenol; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pulmonary Embolism; Rabbits; Rats; Rats, Sprague-Dawley; Thrombosis | 1994 |
[The changes of blood gas analysis values and platelet aggregability on acute phase in the experimental model of pulmonary embolism prepared by sephadex G-75 (SG-75) injection].
Topics: Acute-Phase Reaction; Adenosine Diphosphate; Animals; Blood Gas Analysis; Carbon Dioxide; Dextrans; Disease Models, Animal; Male; Oxygen; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Pulmonary Embolism; Rabbits | 1996 |
Bronchoalveolar lavage alterations in pulmonary embolism.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Albumins; Bronchoalveolar Lavage Fluid; Cell Count; Female; Follow-Up Studies; Humans; Leukocyte Count; Lipids; Macrophages; Male; Middle Aged; Neutrophils; Oxygen; Phospholipases A; Phospholipids; Platelet Activating Factor; Proteins; Pulmonary Embolism; Pulmonary Surfactants; Respiration, Artificial | 1998 |
Effects of inhaled platelet activating factor on bronchial responsiveness in patients with symptomatic and asymptomatic pulmonary embolism.
Topics: Administration, Inhalation; Bronchial Provocation Tests; Bronchoconstriction; Female; Humans; Lung; Male; Methacholine Chloride; Middle Aged; Platelet Activating Factor; Pulmonary Embolism; Radionuclide Imaging | 1992 |
Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease.
Topics: Antithrombin III; Cardiopulmonary Bypass; Child; Follow-Up Studies; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Platelet Activating Factor; Postoperative Complications; Protein C; Pulmonary Embolism; von Willebrand Factor | 1992 |
Effects of platelet activating factor on rat platelets in vivo.
Topics: Adenosine Diphosphate; Animals; Azepines; Blood Platelets; In Vitro Techniques; Leukocytes; Male; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Count; Pulmonary Embolism; Rats; Rats, Inbred Strains; Triazoles | 1991 |